Communication Drug Pricing Pharmaceutical Manufacturing 
Pharmaceutical Commerce
JUNE 17, 2025
Given the strict state and federal regulations governing how manufacturers communicate with or support patients, companies face significant legal and regulatory risk when managing PAP programs.
Pharma Marketing Network
JULY 9, 2025
Or would it unravel under the weight of economic retaliation, manufacturing disruptions, and rising drug prices? Table of Contents The Ripple Effects of Tariffs on Drug Pricing Manufacturing Dependencies and Global Disruption Impact on Pharma Marketing and Innovation Budgets Can the Industry Adapt or Will It Fracture?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Proxsys Rx
APRIL 1, 2025
billion annually because of these restrictions, as drug companies limit 340B discounts on medications purchased through contract pharmacies. billion in 340B savings is at risk, due to increasing limitations imposed by pharmaceutical manufacturers which could further strain the healthcare safety net and patient care services.
Pharmaceutical Technology
JUNE 30, 2025
Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.
Pharmaceutical Technology
JULY 31, 2025
Manasi Vaidya August 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook President Trump has sent letters to several leading pharmaceutical manufacturers outlining steps they need to take in line with the administration’s Most Favored Nation policy to bring down drug prices in the US.
Viseven
MAY 9, 2025
Role of HEOR in Pharmaceutical Industry With budget constraints tightening and drug prices facing greater scrutiny, Health Economics and Outcomes Research has become a cornerstone of modern pharmaceutical strategy. Drug pricing continues to dominate global discussions, ranking as the second major trend.
Proxsys Rx
OCTOBER 6, 2022
That’s why helping health systems minimize data mismatches at the source is so critical to maximizing 340B savings 340B drug pricing program savings for a covered entity — and why meeting that challenge is a core component of our 340B software and service package. There are many places where communication failures can and do occur.
Expert insights. Personalized for you.
Let's personalize your content